Cyclooxygenase-2 (cox-2) as a target of anticancer agents: a review of novel synthesized scaffolds having anticancer and cox-2 inhibitory potentialities

HIGHLIGHTS

• who: Noor ul Amin Mohsin and collaborators from the Department of Pharmaceutical Chemistry, Faculty of Pharmaceutical Sciences, Government College University, Riyadh, Saudi Arabia have published the Article: Cyclooxygenase-2 (COX-2) as a Target of Anticancer Agents: A Review of Novel Synthesized Scaffolds Having Anticancer and COX-2 Inhibitory Potentialities, in the Journal: Pharmaceuticals 2022, 15, x FOR PEER REVIEW of /2022/
• what: __SECTION__ Conclusions.
• how: This review discusses the biological activity of recently prepared dual anticancer and inhibitory agents.
• future: These agents demonstrated prominent anticancer activity in inhibiting CRC and . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.